Projected health impact of post-discharge malaria chemoprevention among children with severe malarial anaemia in Africa
Open Access
- 25 January 2023
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-10
Abstract
Children recovering from severe malarial anaemia (SMA) remain at high risk of readmission and death after discharge from hospital. However, a recent trial found that post-discharge malaria chemoprevention (PDMC) with dihydroartemisinin-piperaquine reduces this risk. We developed a mathematical model describing the daily incidence of uncomplicated and severe malaria requiring readmission among 0–5-year old children after hospitalised SMA. We fitted the model to a multicentre clinical PDMC trial using Bayesian methods and modelled the potential impact of PDMC across malaria-endemic African countries. In the 20 highest-burden countries, we estimate that only 2–5 children need to be given PDMC to prevent one hospitalised malaria episode, and less than 100 to prevent one death. If all hospitalised SMA cases access PDMC in moderate-to-high transmission areas, 38,600 (range 16,900–88,400) malaria-associated readmissions could be prevented annually, depending on access to hospital care. We estimate that recurrent SMA post-discharge constitutes 19% of all SMA episodes in moderate-to-high transmission settings.Keywords
All Related Versions
Funding Information
- Royal Society (Dorothy Hodgkin fellowship)
This publication has 39 references indexed in Scilit:
- Defining the relationship between infection prevalence and clinical incidence of Plasmodium falciparum malariaNature Communications, 2015
- Incidence of catastrophic health expenditures for households: An example of medical attention for the treatment of severe childhood malaria in Kinshasa reference hospitals, Democratic Republic of CongoJournal of Infection and Public Health, 2015
- Gradual acquisition of immunity to severe malaria with increasing exposureProceedings Of The Royal Society B-Biological Sciences, 2015
- Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysisNature Communications, 2014
- Estimates of the changing age-burden of Plasmodium falciparum malaria disease in sub-Saharan AfricaNature Communications, 2014
- Intermittent preventive therapy for malaria with monthly artemether–lumefantrine for the post-discharge management of severe anaemia in children aged 4–59 months in southern Malawi: a multicentre, randomised, placebo-controlled trialThe Lancet Infectious Diseases, 2012
- Modelling the impact of vector control interventions on Anopheles gambiae population dynamicsParasites & Vectors, 2011
- Long Term Outcome of Severe Anaemia in Malawian ChildrenPLOS ONE, 2008
- Suppression of erythropoiesis in malarial anemia is associated with hemozoin in vitro and in vivoBlood, 2006
- Inference from Iterative Simulation Using Multiple SequencesStatistical Science, 1992